- Report
- May 2025
- 120 Pages
Global
From €4337EUR$4,750USD£3,681GBP
- Report
- January 2025
- 250 Pages
Global
From €4564EUR$4,999USD£3,874GBP
- Report
- August 2024
- 200 Pages
Global
From €3533EUR$3,869USD£2,998GBP
- Report
- July 2024
- 200 Pages
Global
From €4519EUR$4,949USD£3,835GBP
- Report
- December 2024
- 200 Pages
Global
From €3424EUR$3,750USD£2,906GBP
- Report
- October 2024
- 200 Pages
Global
From €3424EUR$3,750USD£2,906GBP
- Report
- October 2024
- 200 Pages
Global
From €3424EUR$3,750USD£2,906GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1826EUR$2,000USD£1,550GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1141EUR$1,250USD£969GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1141EUR$1,250USD£969GBP
- Report
- July 2024
- 100 Pages
Global
From €3424EUR$3,750USD£2,906GBP
- Report
- February 2025
- 207 Pages
Global
From €4063EUR$4,450USD£3,448GBP
- Report
- September 2024
- 211 Pages
Global
From €4063EUR$4,450USD£3,448GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1370EUR$1,500USD£1,162GBP
- Report
- July 2024
- 100 Pages
Global
From €3424EUR$3,750USD£2,906GBP
- Report
- July 2024
- 150 Pages
Global
From €3424EUR$3,750USD£2,906GBP
- Report
- July 2024
- 100 Pages
Global
From €3424EUR$3,750USD£2,906GBP
- Report
- July 2024
- 150 Pages
Global
From €3424EUR$3,750USD£2,906GBP
- Report
- July 2024
- 150 Pages
Global
From €3424EUR$3,750USD£2,906GBP
- Report
- July 2024
- 150 Pages
Global
From €3424EUR$3,750USD£2,906GBP

The COVID 19 Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. The market is also focused on the development of treatments and vaccines to combat the virus.
The Diagnostics market is driven by the need for rapid and accurate testing, as well as the need for treatments and vaccines. This has led to an increase in investment in the sector, as well as the development of new technologies and products.
Companies in the COVID 19 Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Show Less Read more